INTRODUCTION
In mammalian and non-mammalian species, hydrophobic xenobiotics bind non-covalently to proteins and lipoproteins, which may facilitate their storage, transport and intracellular distribution and result in gene transcription and activation [1] [2] [3] [4] . Two soluble proteins, aryl hydrocarbon receptor (AhR) and polycyclic aromatic hydrocarbon (PAH)-binding protein, which may be distinguished by their sedimentation in the 8 S and 4 S fractions of sucrose density gradients, respectively, have been studied extensively in rodent livers [2, [4] [5] [6] [7] [8] [9] [10] [11] . The AhR binds several different structural classes of aromatic compounds : halogenated aromatics, e.g. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) ; PAHs, e.g. 3-methylcholanthrene (3-MC) and benzo Key words : 4 S binding protein, rat liver, soluble proteins.
carbons, e.g. β-naphthoflavone (β-NF ; 5,6-benzoflavone). The AhR is a ligand-dependent transcription factor, which via a complex signal-transduction pathway involving interactions with other proteins induces expression of certain phase-I (the CYP1 family of cytochrome P450s) and phase-II oe.g. glutathione Stransferase (GST) Ya, aldehyde-3-dehydrogenase and DTdiaphorase [NAD(P)H : quinone oxidoreductase]q enzymes in xenobiotic metabolism [2] [3] [4] . In addition to binding to the AhR, the PAHs, but not TCDD, bind to a 4 S protein [6, 9, 11, 12] . However, certain highly specific ligands for a 4 S protein with little or no binding for the AhR, e.g. benzo[e]pyrene (B[e]P), induce CYP1A1 gene expression, and thus a function similar to but independent from AhR for the 4 S PAH-binding protein was suggested [13] . In the rat liver, the latter has been identified as glycine N-methyltransferase (GNMT) [14] , which elicits different functions depending on the subunit configurations, e.g. the B[a]P-binding unit of GNMT is a homodimer [15] . The studies in cell cultures support GNMT as a protein which binds PAHs to mediate the induction of CYP1A1 via an AhR-independent mechanism [16, 17] . However, the evidence from other laboratories supports neither the identity of the 4 S PAH-binding protein as GNMT nor its transcriptional function in the gene expression [18, 19] . The dispute suggests that both the identity and role of this protein are yet to be elucidated. The binding characteristics of a 4 S protein were determined with the use of $H-labelled 3-MC and B[a]P as ligands [5, 6, 20, 21] . The affinities of other compounds for this protein were determined from their competitive effects on the binding of the above ligands. Among the competitors tested, β-NF was shown to significantly block specific binding of [$H]3-MC [5, 20] , and that of [$H]B[a]P [21] , thus revealing its high-to-moderate affinity for a 4 S protein in liver cytosols of male Sprague-Dawley (SD) rats. β-NF has been also shown to bind to AhR of rat liver cytosol with an affinity less than that of TCDD and greater or similar to that of B[a]P [10, 22] . Binding of β-NF to liver cytosolic proteins of female SD rats was of particular interest to us since, in our previous study, treatment of these rats with β-NF decreased ($ 70 %) the levels of oestrogen receptor in liver cytosols to an even greater extent than did ovariectomy ($ 30 % decrease) [23] . Although β-NF is not a ligand for oestrogen receptor, its ' antioestrogen-like ' effect resembled that of TCDD and hence might be mediated via AhR [4] .
The purpose of the present study was to determine binding of β-NF to liver cytosolic proteins of female SD rats with the use of [$H]β-NF as the ligand to gain insight into its interaction(s) with relevant receptors. Since specific binding of [$H]β-NF to a 4 S protein was found herein to be significantly induced by treatment of rats with β-NF, the effects of treatment with other potent AhR agonists, TCDD or 3-MC [4] , and α-naphthoflavone (α-NF ; 7,8-benzoflavone), an antagonist of TCDD-induced activation of AhR in rat liver cytosol [24] , on the [$H]β-NF binding activity were also examined. In addition, ligands with known affinities for the 4 S PAH-binding protein were evaluated for competition with [$H]β-NF binding to a 4 S protein of β-NF-, 3-MC-and TCDD-treated rats.
MATERIALS AND METHODS

Materials
The following were purchased from the sources indicated : 
Animals and treatment
Rats were housed in the facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International, and cared for in accordance with [25] [23] . Separate rats were injected intraperitoneally once with β-NF, 3-MC or α-NF at 40 mg\kg b.wt. or the vehicle (corn oil) at 5 ml\kg b.wt. on day 50p2 of age. Four male SD rats were also injected intraperitoneally once with β-NF or vehicle at the above dose levels. All rats were killed (by decapitation under asphyxia with CO # ) 24 h after the injection. Treatment of female rats ($ 55 days old) with one i.p. injection of TCDD at 25 µg\kg b.wt. or the vehicle (corn oil) at 4 ml\kg b.wt. 72 h before killing was adapted from the published protocols [26, 27] and carried out in the laboratory of Dr Karl K. Rozman, University of Kansas Medical Center, Kansas City, KS, U.S.A.
Preparation of liver microsomal and cytosolic fractions
The livers were perfused, removed and frozen as described previously [23] . Hepes buffer, pH 7.6, consisting of 25 mM Hepes, 1.5 mM EDTA, 20 mM sodium molybdate, 1 mM dithiothreitol, 0.5 mM PMSF and 10 % glycerol was used unless stated otherwise. The homogenization of livers and fractionation were described previously [23] . Protein concentration was determined by the method of Bradford [28] . The unbound $H-labelled compounds were removed by addition of 50 µl of a charcoal suspension (3 % charcoal in 0.3 % Dextran T-70), incubation at 4 mC for 10 min and sedimentation at 1500 g for 10 min. Aliquots (100 µl) of the supernatants were layered on to a linear 10-30 % sucrose density gradient (in the Hepes buffer without glycerol) in 4.9 ml OptiSeal Beckman vertical rotor tubes. The gradients were centrifuged at 4 mC for 2 h (unless stated otherwise) at 372 408 g in a Beckman VTi 65.2 rotor, using slow acceleration and deceleration modes. After piercing the bottom of each tube, fractions ($ 5 drops) were added to 5 ml of an Ultima Gold scintillation cocktail (Packard Instrument Co., Meriden, CT, U.S.A.) and the radioactivity was determined with a 1900 CA TriCarb Liquid Scintillation Analyzer (Packard Instrument Co., Downers Grove, IL, U.S.A.). BSA (4.4 S) and catalase (11.3 S) were layered on to separate sucrose gradients as external sedimentation standards.
Assay
Assay of competition for [ 3 H]β-NF binding to liver cytosols from β-NF-, 3-MC-or TCDD-treated rats
Incubation mixtures consisted of aliquots of cytosols containing 75 µg of protein, 500 nM TCDF (added to block [$H]β-NF β-Naphthoflavone-binding protein in rat liver binding to an 8 S protein), 10 nM [$H]β-NF and a 100-fold excess of the unlabelled competitor dissolved in ethanol (final concentration of 3.3 %) in a total volume of 150 µl of the Hepes buffer (without PMSF). After incubation for 4 h at 4 mC, the unbound [$H]β-NF was removed by addition of 300 µl of a suspension of 0.5 % charcoal in 0.05 % Dextran T-70, incubation at 4 mC for 10 min and centrifugation at 1500 g for 15 min. The radioactivity of supernatants was determined in 200 µl aliquots as described above. Dissociation of [$H]β-NF from its cytosolic binding protein(s) was determined by employing the principles of infinite dilution and rebinding prevention [9] . In the first approach, 20 nM [$H]β-NF with and without a 200-fold excess of the unlabelled β-NF and cytosol (1.0 mg of protein\ml) were incubated at 4 mC for 15 h. The unbound β-NF was then removed by addition of 2 vol. of a charcoal suspension and sedimentation. Duplicate aliquots of 150 µl were withdrawn from each supernatant at seven time intervals between 0 and 24 h, treated with a charcoal suspension to remove the dissociated β-NF, centrifuged and radioactivity in the supernatants was determined. In the second approach, a charcoal sediment was added to the incubation mixture after 15 h at 4 mC. After removal of the unbound [$H]β-NF, unlabelled β-NF (4 µM) was added to the supernatant and duplicate aliquots of 150 µl were withdrawn at the same time intervals as above. The dissociated [$H]β-NF was determined by addition of 300 µl aliquots of a charcoal suspension, centrifugation and radioactivity measurements of the supernatants.
Determination of binding kinetics of [ 3 H]β-NF to liver cytosol of β-NF-treated rats
Gel-filtration chromatography
A Sephacryl S-200 HR column (100 cmi1.6 cm inner diameter) and the molecular-mass markers Blue Dextran (2000 kDa), alcohol dehydrogenase (150 kDa), BSA (66 kDa) and cytochrome c (12.4 kDa) were used. Liver cytosolic proteins from β-NF-treated rats were separated on the column at 4 mC before (i) and after (ii) incubation with [$H]β-NF. In (i), an aliquot of cytosol (150 mg of protein in 4.5 ml) was applied to the column and eluted with 25 mM Tris buffer, pH 7.6, containing 1.5 mM EDTA, 5 mM sodium molybdate, 25 mM NaCl, 1 mM dithiothreitol and 0.5 mM PMSF. Fractions ($ 1.7 ml) were collected, frozen in liquid nitrogen and stored at k80 mC for assays of [$H]β-NF-specific binding and enzyme activities. Aliquots (150 µl) of individual fractions were incubated with 20 nM [$H]β-NF for 20 h at 4 mC with and without a 200-fold excess of the unlabelled β-NF, and after removal of the unbound [$H]β-NF through charcoal adsorption and sedimentation, their radioactivities were determined as described above. In (ii), aliquots of cytosols (4.8 mg of protein in 1 ml) were incubated with [$H]β-NF with and without the unlabelled β-NF as described above.
After treatment with charcoal and sedimentation, the supernatants were applied to the column, and eluted with the above buffer. The fractions were collected and their radioactivities determined as described above.
Assays of enzyme activities
Liver microsomal ethoxyresorufin-O-de-ethylase (EROD) [29] and UDP-glucuronosyltransferase [30] activities, cytosolic GNMT [31] , DT-diaphorase [32] , GST [33] and aldehyde-3-dehydrogenase [34] activities were determined by the published procedures.
Statistical analysis
Values are expressed as meanspS.E.M. Significance of difference was assessed by Student's t test (see Table 1 below) or one-way ANOVA followed by Tukey's post test (see Table 2 ) [35] . P 0.05 was considered statistically significant. The effects of competitors on [$H]β-NF binding (see Table 3 ) were examined using a multivariate ANOVA [35] . Percentage binding was compared among the treatment groups for each of the 17 competitors used. Pairwise comparisons of means were conducted using t tests. In addition, t tests were used to determine whether percentage binding for each competitor differed from 100 %, i.e. the control value obtained in the absence of competitor. All tests were adjusted using the Bonferroni method [35] , with the overall level of significance set to α l 0.05.
RESULTS
Effects of treatment of rats with β-NF on specific binding of [ 3 H]β-NF to liver cytosol
Hepatic cytosols used herein were devoid of EROD and UDPglucuronosyltransferase activities and thus considered free of microsomal contamination. After treatment of rats with β-NF (nine i.p. injections at 40 mg\kg b.wt.), the level of [$H]β-NF binding to liver cytosol was 1467p260 fmol\mg of protein, whereas that of control (corn oil-treated) rats was 51p35 fmol\mg of protein, thus yielding a 30-fold increase. The [$H]β-NF binding was non-covalent since it was released by denaturation of the labelled protein(s) with methanol, acetone or trichloroacetic acid. The sucrose density gradients from [$H]β-NF binding to cytosol of β-NF-treated rats contained a large 4 S and a small 8 S peak of radioactivity, indicating binding to two protein fractions (Figure 1 , panels A1 and A2). Whereas coincubation with the unlabelled β-NF eliminated both peaks, co-incubation with TCDF eliminated only the 8 S peak. The sucrose density gradient from [$H]β-NF binding to cytosol of corn oil-treated rats showed only a trace amount of radioactivity in the 4 S region (Table 1) . These results indicate that a constitutive 4 S binding protein is essentially absent but that it is induced 1000-fold by treatment of rats with β-NF. The sucrose density gradient from [$H]TCDD binding to cytosol of β-NFtreated rats yielded a small 4 S peak and a larger 8 S peak ( Figure  1, panel B) . The 8 S, but not the 4 S, peak was abolished by co-incubation with TCDF, which was analogous to the effect on [$H]β-NF binding (Figure 1 , panels A1 and A2). Thus the patterns of sedimentation, distribution and elimination of radioactivity from the 8 S fraction were characteristic for the AhR [6, 11] , whereas those from the 4 S fraction appeared to be specific for β-NF binding. EROD activity are consistent with properties of AhR agonists, the prominent induction of a 4 S [$H]β-NF-binding protein is to our knowledge a novel property of β-NF.
Comparison of the effects of treatment of rats with β-NF, TCDD, 3-MC or α-NF on specific binding of [ 3 H]β-NF to liver cytosol
The effects of treatment of rats with the AhR agonists other than β-NF, i.e. TCDD or 3-MC [4] , or with α-NF, an antagonist of TCDD-induced activation of AhR [24] , on the specific binding Figure 2 ) showed a similar pattern of distribution of radioactivity to that from rats treated with β-NF (nine i.p. injections ; Figure 1 , panels A1 and A2). Thus large and small amounts of radioactivity were associated with a 4 S and an 8 S β-Naphthoflavone-binding protein in rat liver fraction, respectively. Both peaks of radioactivity were eliminated by co-incubation with the unlabelled β-NF and the 8 S but not the 4 S peak by co-incubation with TCDF (shown in Figure 2 , panels A and B, with cytosols from 3-MC-and α-NF-treated rats, respectively). In TCDD-treated rats (72 h after one i.p. injection), the [$H]β-NF binding to liver cytosol was 120-fold greater than in the corn oil-treated controls (Table 2) . Sucrosegradient analyses of [$H]β-NF and [$H]TCDD binding to liver cytosol of TCDD-treated rats showed that the patterns of distribution of the radioactivity and its suppression in the presence of the unlabelled β-NF or TCDF ( Figure 3) were similar to those with liver cytosols from β-NF-, 3-MC-or α-NFtreated rats (Figure 2 ). Co-incubation with TCDF also eliminated the background binding (Figures 2 and 3) . The data indicate that the AhR agonists, TCDD, 3-MC and β-NF, induce a 4 S [$H]β-NF-binding protein in rat liver cytosol. The lower level of induction of [$H]β-NF binding activity and protein in the liver cytosol of α-NF-treated rats ($ 20-25 % the level of 3-MC-or β-NF-treated rats) suggests that α-NF displays a weak AhR agonist activity in i o, which may be similar to that reported for rat liver cytosol in itro [36] . 
H]β-NF to liver cytosol of β-NF-, 3-MC-, α-NF-or corn oil-treated rats
Competitors of [ 3 H]β-NF binding to liver cytosols from β-NF-, 3-MC-or TCDD-treated rats
The patterns of elimination of [$H]β-NF binding to liver cytosols after co-incubation with the unlabelled β-NF and TCDF indicated that β-NF competed with [$H]β-NF for binding to both the 4 S and 8 S proteins whereas TCDF competed for the 8 S protein (Figures 1-3) . Therefore, competition by other compounds with [$H]β-NF for binding to the 4 S protein was examined in the presence of TCDF to eliminate the binding to the 8 S protein (and also the background binding). Competitors of [$H]β-NF binding were determined with liver cytosols from β-NF-, 3-MCor TCDD-treated rats (Table 3) . No statistically significant differences were found among the three treatment groups for any of the 17 compounds Figure 5B ). The molecular mass of a 7 S component is estimated at $ 120 kDa [37] .
Since AhR agonists including β-NF induce several cytosolic enzyme activities, e.g. those of GST Ya, aldehyde-3-dehydrogenase and DT-diaphorase [4] , their elution profiles on Sephacryl β-Naphthoflavone-binding protein in rat liver S-200 were compared with that of [$H]β-NF-binding activity ( Figure 6 ). However, the latter did not co-elute with any of the above enzyme activities. Furthermore, treatment of rats with β-NF significantly decreased (by 63 %) the GNMT activity of liver cytosol (Table 1) . Although this activity was ascribed to a 4 S PAH-binding protein [14] , a later report did not confirm this finding [18] . [21] in liver cytosols of untreated male SD rats. Hence, these rats (either of unknown source, or CD rats from Charles River, Margate, Kent, U.K.) as well as male Wistar [38, 39] and SD rats from Sasco (Omaha, NE, U.S.A.) [11, 12, 40] are considered to be ' 4-Spositive '. By contrast, binding of [$H]B[a]P to a 4 S protein was undetectable in male Harlan SD rats from Houston, TX, U.S.A. (see [12] ), which were thus considered to be ' 4-S-negative ' [12] . In the 4-S-positive male SD rats, the specific [$H]B[a]P-binding activity was increased by pretreatment with phenobarbital or isosafrole, but not with 3-MC [40] . However, in phenobarbitaltreated SD rats (Janvier, Le Genest, France), β-NF exerted only a small competitive effect on the specific binding of [$H]3-MC to a 4 S protein [10] . In our study, there was little or no binding of [$H]β-NF to a 4 S protein in the liver cytosols of the control (corn oil-treated) female Harlan SD rats from Indianapolis, IN, U.S.A. (Table 1) suggesting that they were 4-S-negative. Treatment of these rats with the AhR agonists TCDD, 3-MC or β-NF [4] , and to a lesser extent with α-NF, a weak AhR agonist [36] , induced the [$H]β-NF-binding activity (Table 2 ). This is commensurate with a 4 S [$H]β-NF-binding protein (Figures 1-3) , for which α-NF, β-NF and 3-MC were high-affinity ligands blocking the [$H]β-NF binding by 80 % (Table 3) . A potent inhibition of the [$H]β-NF binding by α-NF was in contrast with its moderateto-weak affinity for the constitutive 4 S PAH-binding protein [5, 20] . On the other hand, the PAHs, e.g. B[a]P, B[e]P, B[ghi ]Per, DMBA or BA, reported to be the high-affinity ligands for the constitutive 4 S PAH-binding protein of liver cytosols from male SD [5, 20] or Long-Evans [7] rats, were only weak ligands for the induced 4 S protein described herein, inhibiting the [$H]β-NF binding by $ 35-5 % (Table 3) . Furthermore, metyrapone,
